Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

St. Jude Epic

This article was originally published in The Gray Sheet

Executive Summary

VR and DR implantable cardioverter defibrillators, approved by FDA in September, store 34 joules of energy and can deliver 30 J, while Guidant's competing Prizm II devices store 31 J and deliver 27 J. "The Gray Sheet" incorrectly reported that the Prizm II devices deliver 31 joules (1"The Gray Sheet" Aug. 26, 2002, p. 34)...

You may also be interested in...



St. Jude Epic

Dual-chamber EpicDR and single-chamber Epic VR implantable cardioverter defibrillators, approved via PMA supplement, will compete with Guidant's Prizm II line of small ICDs. Both the DR and VR devices deliver up to 30 joules of energy; the former measures 33 cc and weighs 70 grams, while the latter measures 32 cc and weighs 69 grams. By comparison, the slightly smaller but heavier Prizm II devices deliver 31 joules. A limited release is scheduled for September...

Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables

Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017197

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel